StockData
Pharma-Bio Serv, Inc. logo

Pharma-Bio Serv, Inc. (PBSV) stock

PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 9/30
$0.48+0.08 (+20.00%)

Close on Oct 19, 2026Market cap $11.00MP/E 48.0Yield –

Pharma-Bio Serv statistics

47 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
Feb 27, 2026
Fundamentals through
Jul 31, 2026
Share price as of
–

Share statisticsIndustry

Shares Change (YoY)
-0.12%
1.02%
Shares Change (QoQ)
0.00%
0.00%
Float
20M
27M
Shares Held by Insiders
10.8%
4.27%

MarginsIndustry

Gross Margin
32.3%
41.3%
Operating Margin
-1.63%
1.24%
Pretax Margin
2.84%
2.70%
Profit Margin
2.65%
0.84%
EBITDA Margin
-1.02%
3.79%
FCF Margin
-4.44%
5.92%

Returns on capitalIndustry

Return on Equity (ROE)
2.25%
1.76%
Return on Assets (ROA)
2.01%
-2.60%
Return on Invested Capital (ROIC)
-9.44%
5.25%
Return on Capital Employed (ROCE)
-1.48%
3.71%

Financial positionIndustry

Current Ratio
11.30
1.36
Quick Ratio
11.06
0.75

GrowthIndustry

Revenue Growth (YoY)
3.25%
5.34%
Revenue Growth (3Y CAGR)
-22.6%
5.14%
Revenue Growth (5Y CAGR)
-16.0%
7.65%

EfficiencyIndustry

Asset Turnover
0.76
0.82
Revenue Per Employee
$49.91K
$215.67K
Profits Per Employee
$1.32K
-$534
Employee Count
190
99

Income statement (TTM)Industry

Revenue
$9.48M
$23.08M
Gross Profit
$3.07M
$19.35M
Operating Income
-$154.94K
-$48.83K
Pretax Income
$269.00K
-$31.25K
Net Income
$251.53K
-$62.45K
EBITDA
-$97.01K
-$25.17K
EPS (Diluted)
$0.01
$0.00

Balance sheetIndustry

Net Cash (Debt)
$8.58M
$15.49K
Net Cash Per Share
$0.37
$0.00
Equity (Book Value)
$10.44M
$10.55M
Book Value Per Share
$0.46
$0.73
Tangible Book Value
$10.44M
$13.82K
Working Capital
$10.24M
$4.37M

Cash flow (TTM)Industry

Operating Cash Flow
-$414.89K
$41.37K
Capital Expenditures
-$6.47K
-$6.55M
Free Cash Flow
-$421.36K
$6.94M
FCF Per Share
-$0.02
$0.47

Taxes and interestIndustry

Income Tax
$17.47K
$1.16M
Effective Tax Rate
6.50%
24.1%

Scores and fair valueIndustry

Graham Number
$0.32
$19.24
Piotroski F-Score
5
5
Beneish M-Score
-2.93
-2.75

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodPBSVS&P 500DifferencePBSV per yearS&P 500 per year
1 month+4.3%+0.6%+3.7 pts
3 months-4.0%+3.4%−7.4 pts
Year to date-8.3%+13.3%−21.6 pts
1 year-10.2%+16.6%−26.8 pts
3 years-23.0%+86.4%−109.4 pts-8.4%+23.1%
5 years-14.5%+81.9%−96.3 pts-3.1%+12.7%
10 years+11.2%+318.9%−307.6 pts+1.1%+15.4%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M PBSV shares were sold short on Oct 30, 2026, up 0.0% from the previous report. At recent volumes it would take 1.0 days to buy them back.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20262,0080.0%3,3671.0
Oct 15, 20262,008+109.6%13,0201.0
Sep 30, 2026958–6,5451.0
Dec 15, 2025404–1,6781.0
Oct 31, 20251,907-77.6%6,7761.0
Oct 15, 20258,505-53.7%3,0672.8
Sep 30, 202518,384+318.6%25,5331.0
Sep 15, 20254,392–23,2691.0
Jul 31, 2025213+67.7%14,7981.0
Jul 15, 2025127+30.9%15,5921.0
Jun 30, 202597–5,0501.0
May 30, 2025261+44.2%3,6341.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?